Vertex Pharmaceuticals
VRTX
#147
Rank
A$201.95 B
Marketcap
A$796.56
Share price
0.85%
Change (1 day)
26.37%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): A$25.56

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$25.23. In 2025 the company made an earnings per share (EPS) of A$22.52 an increase over its 2024 EPS that were of A-$3.00.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$25.5613.48%
2025A$22.52-850.97%
2024A-$3.00-114.67%
2023A$20.448.17%
2022A$18.9042.64%
2021A$13.25-12.67%
2020A$15.17128.01%
2019A$6.65-44.54%
2018A$12.00670.09%
2017A$1.56-327.66%
2016A-$0.68-79.65%
2015A-$3.36-26.43%
2014A-$4.5753.92%
2013A-$2.97316.33%
2012A-$0.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.73-61.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$5.20-79.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.51-117.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.45-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.58-73.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
A-$3.51-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA